Related references
Note: Only part of the references are listed.Histone acetyltransferase p300 is a coactivator for transcription factor REL and is C-terminally truncated in the human diffuse large B-cell lymphoma cell line RC-K8
Michael R. Garbati et al.
CANCER LETTERS (2010)
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Ryan D. Morin et al.
NATURE GENETICS (2010)
A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo
Leandro C. Cerchietti et al.
BLOOD (2009)
The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL
Weimin Ci et al.
BLOOD (2009)
Systematic in vivo structure-function analysis of p300 in hematopoiesis
Erin A. Kimbrel et al.
BLOOD (2009)
The heat shock protein 90 inhibitor IPI-504 induces apoptosis of AKT-dependent diffuse large B-cell lymphomas
Jeremy S. Abramson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
被撤回的出版物: HDAC6 Modulates Hsp90 Chaperone Activity and Regulates Activation of Aryl Hydrocarbon Receptor Signaling (Retracted article. See vol. 295, pg. 297, 2020)
Vikram D. Kekatpure et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Sohrab P. Shah et al.
NATURE (2009)
A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas
Leandro C. Cerchietti et al.
NATURE MEDICINE (2009)
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
Chunaram Choudhary et al.
SCIENCE (2009)
Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma
M. Crump et al.
ANNALS OF ONCOLOGY (2008)
Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma:: an international collaborative study
Ken H. Young et al.
BLOOD (2008)
Role of acetylation and extracellular location of heat shock protein 90α in tumor cell invasion
Yonghua Yang et al.
CANCER RESEARCH (2008)
Sequential transcription factor targeting for diffuse large B-Cell lymphomas
Leandro C. Cerchietti et al.
CANCER RESEARCH (2008)
B-cell lymphoma 6 and the molecular pathogenesis of diffuse large B-cell lymphoma
Weimin Ci et al.
CURRENT OPINION IN HEMATOLOGY (2008)
Targeting Hsp90: small-molecule inhibitors and their clinical development
Tony Taldone et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Current treatment approaches for diffuse large B-cell lymphoma
Tim Illidge et al.
LEUKEMIA & LYMPHOMA (2008)
The structural basis of protein acetylation by the p300/CBP transcriptional coactivator
Xin Liu et al.
NATURE (2008)
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma
J. Iqbal et al.
LEUKEMIA (2007)
Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma
Yen-Shen Lu et al.
HEPATOLOGY (2007)
A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma
Masumichi Saito et al.
CANCER CELL (2007)
Hydroxamic acid analogue histone deacetylase inhibitors attenuate estrogen receptor-α levels and transcriptional activity:: A result of hyperacetylation and inhibition of chaperone function of heat shock protein 90
Warren Fiskus et al.
CLINICAL CANCER RESEARCH (2007)
Transcriptional signature with differential expression of BCL6 target genes accurately identifies BCL6-dependent diffuse large B cell lymphomas
Jose M. Polo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
An acetylation site in the middle domain of Hsp90 regulates chaperone function
Bradley T. Scroggins et al.
MOLECULAR CELL (2007)
STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas
S. R. Walker et al.
ONCOGENE (2007)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma
L Pasqualucci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Targeting chaperones in transformed systems - a focus on Hsp90 and cancer
G Chiosis
EXPERT OPINION ON THERAPEUTIC TARGETS (2006)
Synthesis and evaluation of a potent and selective cell-permeable p300 histone acetyltransferase inhibitor
YJ Zheng et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Abrogation of heat shock protein 70 induction as a strategy, to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin.
F Guo et al.
CANCER RESEARCH (2005)
Expression of heat-shock protein-90 in non-Hodgkin's lymphomas
JR Valbuena et al.
MODERN PATHOLOGY (2005)
Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein
F Guidez et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice
G Cattoretti et al.
CANCER CELL (2005)
Cotreatment with suberanoylanilide hydroxamic acid and 17-allylamino 17-demethoxygeldanamycin synergistically induces apoptosis in Bcr-Abl+ cells sensitive and resistant to STI571 (imatinib mesylate) in association with down-regulation of Bcr-Abl, abrogation of signal transducer and activator of transcription 5 activity, and bax conformational change
M Rahmani et al.
MOLECULAR PHARMACOLOGY (2005)
E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation
MC Thomas et al.
MOLECULAR CELL (2005)
Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines
S Sakajiri et al.
EXPERIMENTAL HEMATOLOGY (2005)
Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53
W An et al.
CELL (2004)
Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain
KF Ahmad et al.
MOLECULAR CELL (2003)
The Stress Response: Implications for the Clinical Development of Hsp90 Inhibitors
Luke Whitesell et al.
CURRENT CANCER DRUG TARGETS (2003)
Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas
L Pasqualucci et al.
NATURE (2001)
Share Paper
